chartexchange

PHIO
Phio Pharmaceuticals Corp. Common Stock
stockNASDAQ

At CloseNov 18, 2026 2:47:49 PM EST
0.74USD+3.862%(+0.03)63,699
Pre-marketNov 18, 2026 8:51:30 AM EST
0.7337USD+2.301%(+0.0165)
After-hoursNov 18, 2026 4:00:30 PM EST
0.7203USD-3.302%(-0.0246)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Marlborough, MA, USA
Previous Close
$0.72
Beta
1.12
52-Week High
$1.88 2026-02-13
52-Week Low
$0.70 2026-11-17
SMA 50
$0.92
SMA 200
$1.07
Avg. Vol 10D
80,253
Avg. Vol 30D
69,112
Avg. Vol 90D
433,571
Relative Vol
0.92
10.15M
24.7400%
7,290
Jul 5, 2024 · 1-for-9 (reverse)
PHIO Profile

phio pharmaceuticals corp., a biotechnology company, develops immuno-oncology therapeutics in the united states. it offers intasyl therapeutic platform focuses on silencing tumor-induced suppression of the immune system. the company develops ph-762 which targets the checkpoint protein pd-1 on immune cells for used in adoptive cell transfer (act); ph-804 that targets the suppressive immune receptor tigit, which is a checkpoint protein present on t cells and natural killer cells for used in act; and ph-790 which targets pd-l1 protein that keeps immune cells from attacking nonharmful cells in the body. it has collaborations with the gustave roussy and medigene ag, as well as with helmholtz zentrum mã¼nchen. the company was formerly known as rxi pharmaceuticals corporation and changed its name to phio pharmaceuticals corp. in november 2018. phio pharmaceuticals corp. was incorporated in 2011 and is headquartered in marlborough, massachusetts.

PHIO Performance
PeriodPriceDateChangeBeta
1W0.812026-11-12-11.35%0.342
1M0.872026-10-19-17.17%1.498
3M1.152026-08-19-37.42%1.076
6M1.062026-05-19-32.10%0.976
1Y1.252025-11-19-42.42%1.121
2Y2.552024-11-19-71.80%—
5Y147.962021-11-19-99.51%1.144
PHIO Stock Summary

Phio Pharmaceuticals Corp. Common Stock (NASDAQ:PHIO) stock price today is $0.72, and today's volume is 63,699. PHIO is up 0.349% today. The 30 day average volume is 69,112. PHIO market cap is $8.60M with 11.95M shares outstanding.